Mechanisms of fever induced by recombinant human interferon.
Open accessThe DOI matches its Crossref record.
Abstract
Since the early trials using human interferon (hIFN) derived from blood leukocytes or cell lines, fever has been a prominent component of IFN therapy. Human protein impurities might account for the fever to cell-derived hIFN, but recombinant hIFN, free of extraneous human proteins, has produced fever in nearly all recipients during clinical trials. Our present studies were carried out to determine the mechanisms of fever due to recombinant hIFN currently being used in humans. Because recombinant hIFN is produced in Escherichia coli, in these experiments we considered contaminating endotoxin as the cause of fever. Polymyxin B, which blocks endotoxin, had no effect on the pyrogenicity of hIFN in rabbits. In addition, hIFN injected into an endotoxin-resistant strain of mice produced fever. The pyrogenicity of hIFN does not appear to involve production of leukocytic pyrogen (LP), since no circulating LP was detected in rabbits during IFN fever. Furthermore, human mononuclear cells incubated with hIFN in vitro at 10(4)-10(6) U/ml did not release LP. However, hIFN stimulated prostaglandin E2 (PGE2) release from rabbit hypothalamic tissue in vitro. Intracerebroventricular injection of hIFN into the awake cat also produced fever and a rise in PGE2 levels in the cerebrospinal fluid; both effects were reversed by treatment with indomethacin. We conclude that the fever of recombinant hIFN is not due to endotoxin but that hIFN is intrinsically pyrogenic by inducing PGE2 in the hypothalamus.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1.
Dinarello, C. A., Cannon, J. G., Wolff, S. M., Bernheim, H. A., Beutler, B., Cerami, A., Figari, I. S., Palladino, M. A., & O'Connor, J. V. (1986) · The Journal of experimental medicine · doi:10.1084/jem.163.6.1433 · Cited by 1,472
Self-citationThere is more than one interleukin 1
Oppenheim, J. J., Kovacs, E. J., Matsushima, K., & Durum, S. K. (1986) · Immunology Today · doi:10.1016/0167-5699(86)90124-6 · Cited by 1,203
Clinical toxicity of interferons in cancer patients: a review.
Quesada, J. R., Talpaz, M., Rios, A., Kurzrock, R., & Gutterman, J. U. (1986) · Journal of Clinical Oncology · doi:10.1200/jco.1986.4.2.234 · Cited by 596
Perioperative thermoregulation and heat balance
Sessler, D. I. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00981-2 · Cited by 593
Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed
Dinarello, C. A. (2004) · Journal of Endotoxin Research · doi:10.1179/096805104225006129 · Cited by 435
Self-citationPsychiatric Complications of Long-term Interferon Alfa Therapy
Renault, P. F. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370090055011 · Cited by 413
Cytokines as Endogenous Pyrogens
Dinarello, C. A. (1999) · The Journal of Infectious Diseases · doi:10.1086/513856 · Cited by 387
Self-citationAn update on human interleukin-1: From molecular biology to clinical relevance
Dinarello, C. A. (1985) · Journal of Clinical Immunology · doi:10.1007/bf00918247 · Cited by 374
Self-citationFlier, J. S., Underhill, L. H., Saper, C. B., & Breder, C. D. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406303302609 · Cited by 374
New Concepts on the Pathogenesis of Fever
Dinarello, C. A., Cannon, J. G., & Wolff, S. M. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.1.168 · Cited by 367
Self-citationCirculating Cytokines as Mediators of Fever
Netea, M. G., Kullberg, B. J., & Van der Meer, J. W. M. (2000) · Clinical Infectious Diseases · doi:10.1086/317513 · Cited by 357
Cunningham, C., Campion, S., Teeling, J., Felton, L., & Perry, V. H. (2007) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2006.12.007 · Cited by 318
Side Effects of Interferon-α Therapy
Sleijfer, S., Bannink, M., Gool, A. R., Kruit, W. H. J., & Stoter, G. (2005) · Pharmacy World & Science · doi:10.1007/s11096-005-1319-7 · Cited by 276
Fever induction pathways: evidence from responses to systemic or local cytokine formation
Roth, J., & de Souza, G. E. P. (2001) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2001000300003 · Cited by 194
“Invading viruses or synthetic viral compounds activate a distinct pattern of cytokine production including interferons as initial mediators within the cytokine cascade (10).”
BackgroundTosun, M., Celik, H., Avci, B., Yavuz, E., Alper, T., & Malatyalioğlu, E. (2010) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767051003774942 · Cited by 185
“It circulates throughout the body responding the stimuli, like tissue injury or infectious agents by activating neutrophils and changing the endothelial cell functions [11,12].”
BackgroundFever: Causes and consequences
Moltz, H. (1993) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80009-0 · Cited by 183
Dinarello, C. A., Cannon, J. G., Mancilla, J., Bishai, I., Lees, J., & Coceani, F. (1991) · Brain Research · doi:10.1016/0006-8993(91)90622-3 · Cited by 164
Self-citationInhibition of brain cyclooxygenase-2 activity and the antipyretic action of nimesulide
Taniguchi, Y., Yokoyama, K., Inui, K., Deguchi, Y., Furukawa, K., & Noda, K. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(97)00183-0 · Cited by 65
Metadata
- Authors
- Dinarello, C. A., Bernheim, H. A., Duff, G. W., Le, H. V., Nagabhushan, T. L., Hamilton, N. C., & Coceani, F.
- Venue
- Journal of Clinical Investigation
- Published
- 1984-09-01
- Volume
- 74
- Issue
- 3
- Pages
- 906-913
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2128003655
- Cited by
- 226
- References
- 0
- FWCI
- 26.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.